The Estée Lauder Companies Inc. is teaming up with biotechnology company Serpin Pharma to determine how Serphin's anti-inflammatory research can be applied in skin care longevity cosmetics.
The move comes amid an uptick in The Estée Lauder Companies' (ELC) research collaborations.
Recently, ELC teamed up with MIT’s Robert Langer Lab to develop innovative beauty ingredient technologies, including biodegradable materials and solutions to combat the effects of sunlight and blue light on the skin.
This collaboration builds on ELC's recent advancements, such as its partnership with Exuud Inc. for smart fragrance delivery systems, and the launch of its BioTech Hub in Belgium to produce bio-based raw materials.
The exclusive ELC-Serpin Pharma partnership will tap proprietary biotech technology "demonstrating remarkable efficacy mitigating harmful inflammation and enhancing cell resiliency," per an official announcement.
Serpin Pharma's research centers on serine protease inhibitors (SERPINs), which boost the body's ability to heal cells undergoing inflammation.
Furthermore, its technology can be applied in solutions for skin irritation, aging and sensitivity, according to the companies.
Studies are currently underway for the application of Serpin’s technology in cosmetic products designed to rapidly and visibly reduce skin aging and irritation.
“This novel technology will advance our transformative innovation agenda by pushing the boundaries of breakthrough scientific discovery,” said Carl Haney, executive vice president, global innovation and research and development (R&D), The Estée Lauder Companies. “In partnership with Serpin Pharma, we’re exploring powerful new biological pathways and cutting-edge biotech ingredients to rapidly mitigate visible skin irritation and sensitivity for our prestige beauty consumers worldwide.”
“Serpin Pharma was founded on the principles of biomimicry and how nature solves for signs of trauma and injury,” said Cohava Gelber, Ph.D., MBA, founder, executive chairperson and CEO, Serpin Pharma. “We’re taking a novel approach by tapping into the body’s innate mechanism for resolving inflammation. We are proud to partner with ELC to explore how our powerful biotechnology can be applied to cosmetics and skin care.”
